Response to letter from Dr Martin Bojar and colleagues regarding the article ‘Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis’ by Ravnborg et al. Mult Scler 2009;15:323-328
Restricted accessOtherFirst published online December, 2010
Response to letter from Dr Martin Bojar and colleagues regarding the article ‘Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis’ by Ravnborg et al. Mult Scler 2009;15:323-328
Ravnborg M., Bendtzen K., Christensen O., Jensen PE, Hesse D., Tovey MG, et al. Treatment with azathioprine; cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis. Mult Scler2009; 15(3): 323-328.
2.
Pozzilli C., Antonini G., Bagnato F., Mainero C., Tomassini V., Onesti E., et al. Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis. J Neurol2002; 249(1): 50-56.
3.
Hesse D., Frederiksen JL, Koch-Henriksen N., Schreiber K., Stenager E., Heltberg A., et al. Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon-beta. Eur J Neurol2009; 16(1): 43-47.
4.
Petersen B., Bendtzen K., Koch-Henriksen N., Ravnborg M., Ross C. and Sorensen PSPersistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis. Mult Scler2006; 12(3): 247-252.
5.
Sorensen PS, Mellgren SI, Svenningsson A., Elovaara I., Frederiksen JL, Beiske AG, et al. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial. Lancet Neurol2009; 8(6): 519-529.
6.
Ravnborg M., Sorensen PS, Andersson M., Celius EG, Jongen PJ, Elovaara I., et al. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial. Lancet Neurol2010; (7): 646-647.
